Desregulación microRNAS plasmáticos asociados riesgo cardiovascular en población pediátrica obesa

Scientific concepts, discoveries, and nature/biomedical phenomena

Pediatric obesity and cardiovascular risk

• High prevalence of childhood obesity in Mexico (reported as ~18% for pediatrics; also ~19% overweight mentioned elsewhere).
• Obesity is multifactorial: diet, congenital factors, and endocrine dysregulation/genetic issues (example discussed: hypothyroidism).
• Limitations of BMI in children
  • BMI (and BMI percentile) can misclassify because it does not separate fat vs. muscle mass, especially during growth.
  • Alternative measures mentioned:
    • Adiposity via waist circumference and InBody (tissue/mass distribution).
    • Metabolic health via clinical chemistry (lipoproteins; LDL/HDL; triglycerides; glucose; glycosylated hemoglobin) and indices like HOMA.
• Adipose tissue remodeling in obesity
  • Hypertrophy: increased adipocyte cell size and expansion of the storage compartment for triglycerides.
  • Hyperplasia: increased cell proliferation.
  • Increased secretion of pro-inflammatory cytokines and endocrine dysfunction, turning adipose tissue into a driver of systemic inflammation.

Leptin, sympathetic activation, and RAAS (renin–angiotensin–aldosterone system)

• Leptin dysregulation from expanded adipose tissue:
  • Leptin reaches the brain (including hypothalamic regions) and promotes sympathetic system activation.
• Prostaglandin-mediated signaling described as linking hypothalamic signaling to kidney mechanisms.
• RAAS pathway described conceptually:
  1. Sympathetic/prostaglandin signals and other triggers promote renin release from the juxtaglomerular apparatus.
  2. Renin acts on angiotensinogen → angiotensin I → angiotensin II (via ACE).
  3. Angiotensin II promotes aldosterone synthesis.
  4. Aldosterone increases sodium and water reabsorption → increased plasma volume.
• In obesity, the renin–angiotensin–aldosterone feedback cycle is described as persistently reactivated, contributing to hypertension and cardiovascular strain.

Cardiac remodeling and fibrosis from chronic overload

Chronic hypertension and mechanical stress lead to:

• Cardiac hypertrophy (described mechanistically as cell stress responses).
• Over time, cell loss via apoptosis.
• Replacement with fibrosis (collagen deposition; type I and type III context mentioned), reducing cardiac pumping capacity.

---

MicroRNAs and the study’s main biomarker: miR-7A-5P (as stated)

What microRNAs are (general mechanism)

• MicroRNAs (typically ~22 nucleotides) regulate gene expression post-transcriptionally by binding mRNA (to polyadenine-related regions) and reducing protein expression.
• They may participate in epigenetic modulation across tissues.
• They can be packaged/released via multivesicular bodies/extracellular vesicles into circulation.

Why miR-7A-5P is relevant to cardiovascular health

The speaker’s stated rationale:

• miR-7A-5P can inhibit cardiovascular-relevant genes, including:
  • Endothelin-1 (a potent vasoconstrictor; described as risky when dysregulated).
  • A gene related to heart development/differentiation (reduced expression in heart conditions such as endothelial insufficiency is mentioned).
• Proposed cardioprotective role:
  • Reducing harmful vasoconstrictive signaling and modulating differentiation pathways.

---

Study methodology (as described) — outline

• Setting / participants
  • Project conducted at Federico Gómez Children’s Hospital.
  • Children aged 6–10 years.
  • Groups: obese vs non-obese/control (non-obese also referred to as normopeso in conclusions).
• Sample processing
  • Blood collected.
  • Plasma separated from the cellular fraction.
  • Biochemical profiles measured.
• miRNA measurement
  • Qualitative real-time PCR to assess relative expression of miR-7A-5P.
• Bioinformatics + statistics
  • Bioinformatics enrichment to identify signaling pathways likely regulated by miRNA targets.
  • Statistical analysis applied to PCR results.
• Modeling / performance
  • ROC curve analysis to evaluate discrimination between groups.
  • Correlation analysis (Pearson) between miRNA expression and triglycerides.

---

Key results (biomarker + pathway findings)

Clinical/metabolic differences between groups

• Anthropometrics
  • BMI and BMI percentile differed significantly between obese and control (p < 0.05).
• Blood pressure
  • Systolic and diastolic blood pressure higher in the obese group.
• Biochemical markers
  • Triglycerides increased in the obese group.
  • Insulin and HOMA index increased, indicating metabolic disturbance.

miR-7A-5P expression pattern

• miR-7A-5P was significantly underexpressed in children with obesity.
  • Reported as ~2.6 times underexpressed (speaker wording: “twice (2.6 times)”).
• Discrimination ability (biomarker performance)
  • ROC AUC ~0.809 for miR-7A-5P alone (described as “moderately high” discrimination; ~95% CI mentioned).
  • Combining miR-7A-5P with triglycerides improved discrimination:
    • ROC AUC ~0.869.

Relationship with triglycerides

• Negative significant correlation between triglycerides and miR-7A-5P expression:
  • Pearson R ~ -0.45 (moderate, negative).
  • Interpretation: higher triglycerides correspond to lower miR-7A-5P.

Pathway enrichment from miRNA target analysis

Pathways described as significantly decreased / inhibited by miRNA action:

• MAP kinase signaling
• p53
• TGF-β (Tumor Growth Factor beta)
• PI3K/AKT signaling
• WNT signaling
• Grouped signals associated with type 2 diabetes

The speaker ties these directions to:

• Balance between physiological vs pathological hypertrophy
• Inflammation links (TGF-β/p53 aligned with chronic low-grade inflammation in obesity)
• Lipogenesis/lipogenesis-related signaling (WNT and “diplogenesis” mentioned)
• The triglyceride association (miRNA inhibition aligned with lipid-pathway changes)

---

Conclusion claims (as stated)

• miR-7A-5P shows:
  • Moderate discriminatory capacity to classify obese vs non-obese children.
  • Improved performance when combined with triglycerides.
  • Potential involvement in cardioprotection and modulating dysgenesis/remodeling (as described).
• Proposed biological link:
  • Obesity shifts signaling toward pathological cardiac remodeling; reduced miR-7A-5P may contribute to losing balance between protective vs harmful hypertrophy/inflammation/lipid-related signaling.

---

Researchers / sources featured (named in the subtitles)

• Omar Gómez Acuña (speaker/presenter)
• Dr. Alejandra Contreras (encouraging participation)
• Dr. Alejandra Contral Ramos (project advisor; name appears with subtitle errors)
• Dr. Guadalupe Díaz Rosas (project advisor; name appears with subtitle errors)
• Dr. Palazolos (host/participant greeting)
• Sergio Sárate (participant)
• Carlos Padilla (participant)
• Ali (participant; name as shown)
• Roberto Carlos (Carlos Padilla appears to be the one speaking; subtitle text includes “Roberto Carlos”)
• Marqueiño / Angi / Angelica (questioner; exact spelling uncertain)
• Epigmenio Díaz Vázquez (participant)
• Yuli Cornelis (participant)
• UNAM (institution referenced; not a researcher)
• Chava Flores / Salvador Flores Rivera (song performer/biographical mention during closing segment)